Aerovate Therapeutics, Inc. (AVTE) Operating Lease, Liability USD 2021 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Aerovate Therapeutics, Inc. quarterly Operating Lease, Liability history and growth rate from 2021 to 2024.
  • Aerovate Therapeutics, Inc. Operating Lease, Liability for the quarter ending March 31, 2024 was $774 K, a 19.7% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $774 K -$190 K -19.7% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $675 K -$415 K -38.1% Dec 31, 2023 10-Q 2024-05-13
Q3 2023 $809 K -$370 K -31.4% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $855 K -$354 K -29.3% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $964 K +$436 K +82.6% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $1.09 M +$516 K +89.9% Dec 31, 2022 10-K 2024-03-25
Q3 2022 $1.18 M +$580 K +96.8% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.21 M Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $528 K Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $574 K Dec 31, 2021 10-K 2023-03-29
Q3 2021 $599 K Sep 30, 2021 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.